As the Company prepares for commercialization, RetinalGenix requires a financial, strategic, and operational leader who understands regulated medical devices, clinical development, reimbursement ...
The Company ended its FY 2025 fourth quarter with $1.26 billion in cash and cash equivalents, compared to $1.30 billion at FYE 2024 and $852.3 million at FY 2025's third quarter. At FY 2025 fourth ...
Online privacy, automation, and data intelligence are no longer niche needs; they are the backbone of how businesses and power users operate in 2026. Whether you manage hundreds of online accounts, ...
The Company anticipates closing the financing on December 17, 2025, subject to the standard five-day notice period required by the Canadian Securities Exchange (the “Exchange”).
The Mercury on MSN
Prosecutors fight Lansdale woman’s request to withdraw plea in school threats case
Montgomery County prosecutors are fighting a Lansdale woman’s request to withdraw her no contest plea and to vacate her ...
The US Department of Justice recently displayed its commitment to enforcement of the Foreign Corrupt Practices Act (FCPA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback